Rapid risk/outbreaks assessment aim at supporting the countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for response. As outbreaks or public health events develop, ECDC may issue updated risk assessments.
Italy is currently experiencing four clusters of autochthonous chikungunya cases in the cities of Anzio, Latina and Rome in the Lazio region, and the city of Guardavalle Marina in the Calabria region.
Two related clusters involving autochthonous transmission of chikungunya virus have been detected in the cities of Anzio and Rome. This rapid risk assessment provides detailed event background information and assesses the threat for the European Union.
This rapid risk assessment has been produced In the context of a cluster of four confirmed cases and one probable locally-acquired case of chikungunya in Var department, in southern France.
On 24 March 2017, the German authorities reported the contamination of a ‘do-it-yourself’ bacterial gene engineering CRISPR kit produced in the US. This publication assesses the risk related to the use of ‘do-it-yourself’ CRISPR-associated gene engineering kit contaminated with pathogenic bacteria.
On 31 August 2016 the autonomous Community of Madrid, Spain, reported two cases of infection with Crimean–Congo haemorrhagic fever (CCHF) virus. This document assesses the risk associated with the occurrence of two cases of Crimean–Congo haemorrhagic fever in Spain.
This document assesses the risk to human health posed by a multi-country foodborne outbreak of Shiga toxin-producing Escherichia coli (STEC) infections associated with haemolytic uraemic syndrome taking place in the European Union (EU).
This risk assessment considers the outbreak of chikungunya on the Caribbean island of Saint Martin in early December 2013 which expanded through the Caribbean during the first half of 2014. This is the first documented autochthonous transmission of chikungunya virus in the Americas.